Atrial Fibrillation Screening in Those with Rheumatic Heart Disease: A Narrative Policy Content Review
References
- Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. The New England Journal of Medicine. 2017;377:713–722. DOI: 10.1056/NEJMoa1603693
- World Health Organization. WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease. Geneva: World Health Organization; 2024. p. xviii, p. 53; Permanent URL to the web annex A document:
https://iris.who.int/handle/10665/379107 ; Permanent URL to the web annex B document:https://iris.who.int/handle/10665/379278 . - Morais H, da Silva Ferreira H. Prevalence of rheumatic heart disease diagnosed according to the echocardiographic criteria of the World Heart Federation in Africa: A systematic review and meta-analysis. Cardiovascular Revascularization Medicine. 2024;68:73–78. DOI: 10.1016/j.carrev.2024.05.025
- Australian institute of Health and Welfare (AIHW). Acute rheumatic fever and rheumatic heart disease in Australia.
https://www.aihw.gov.au/reports/indigenous-australians/arf-rhd/contents/rhd/rhd-in-qld-wa#Figure_4_2 . - Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: Clinical implications. Journal of American College of Cardiology. 2001;37:371–378. DOI: 10.1016/S0735-1097(00)01107-4
- Hughes M, Lip GY, Guideline Development Group, NCGfMoAF in Primary and Secondary Care, National Institute for Health and Clinical Excellence. Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thrombosis and Haemostasis. 2008;99:295–304. DOI: 10.1160/TH07-08-0508
- Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, et al. Screening for atrial fibrillation: A report of the AF-SCREEN international collaboration. Circulation. 2017;135:1851–1867. DOI: 10.1161/CIRCULATIONAHA.116.026693
- Linz D, Gawalko M, Betz K, Hendriks JM, Lip GYH, Vinter N, et al. Atrial fibrillation: Epidemiology, screening and digital health. The Lancet Regional Health – Europe. 2024;37:
100786 . DOI: 10.1016/j.lanepe.2023.100786 - Lowres N, Olivier J, Chao TF, Chen SA, Chen Y, Diederichsen A, et al. Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: A multicountry patient-level meta-analysis of 141,220 screened individuals. PLoS Medicine. 2019;16:
e1002903 . DOI: 10.1371/journal.pmed.1002903 - Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine. 2007;146:857–867. DOI: 10.7326/0003-4819-146-12-200706190-00007
- Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJ, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). European Heart Journal. 2024;45(36):3314–3414. DOI: 10.1093/eurheartj/ehae176
- Mant J, Modi RN, Dymond A, Armstrong N, Burt J, Calvert P, et al. Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: Protocol for the SAFER trial. BMJ Open. 2024;14:
e082047 . DOI: 10.1136/bmjopen-2023-082047 - Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, et al. Acute rheumatic fever and rheumatic heart disease. Nature Reviews Disease Primers. 2016;2:
15084 . DOI: 10.1038/nrdp.2015.84 - Noubiap JJ, Nyaga UF, Ndoadoumgue AL, Nkeck JR, Ngouo A, Bigna JJ. Meta-analysis of the incidence, prevalence, and correlates of atrial fibrillation in rheumatic heart disease. Global Heart. 2020;15:
38 . DOI: 10.5334/gh.807 - Chan NY, Orchard J, Agbayani MJ, Boddington D, Chao TF, Johar S, et al. 2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening. Journal of Arrhythmia. 2022;38:31–49. DOI: 10.1002/joa3.12669
- Zuhlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Cupido-Katya Mauff B, et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low- and middle-income countries: Two-year follow-up of the global rheumatic heart disease registry (the REMEDY Study). Circulation. 2016;134:1456–1466. DOI: 10.1161/CIRCULATIONAHA.116.024769
- Group NCAFGW, Brieger D, Amerena J, Attia J, Bajorek B, Chan KH, et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Heart, Lung and Circulation. 2018;27:1209–1266. DOI: 10.1016/j.hlc.2018.06.1043
- Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, et al. 2021 Focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: Executive summary. Thrombosis Haemostasis. 2022;122:20–47. DOI: 10.1055/s-0041-1739411
- Orchard J, Lowres N, Neubeck L, Freedman B. Atrial fibrillation: Is there enough evidence to recommend opportunistic or systematic screening? International Journal of Epidemiology. 2018;47:1372–1378. DOI: 10.1093/ije/dyy111
- NICE. Atrial fibrillation: diagnosis and management (NICE guideline NG196). In: Excellence NIfHaC, (ed).
https://www.nice.org.uk/guidance/ng196 ; 2021. - Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2023;149(1). DOI: 10.1161/CIR.0000000000001193
- Stott DJ, Dewar RI, Garratt CJ, Griffith KE, Harding NJ, James MA, et al. RCPE UK Consensus Conference on ‘approaching the comprehensive management of atrial fibrillation: Evolution or revolution?’ The Journal of Royal College of Physicians of Edinburgh.
2012 ;42:34–35. DOI: 10.4997/JRCPE.2012.S01 - Health Information and Quality Authority. Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care.
https://www.hiqa.ie/publications/health-technology-assessment-hta-national-screening-programme-atrial-fibrillation-prima (24 May 2016). - Magalhaes LP, Figueiredo MJO, Cintra FD, Saad EB, Kuniyoshi RR, Menezes Lorga Filho A, et al. Executive summary of the II Brazilian guidelines for atrial fibrillation. The Arquivos Brasileiros de Cardiologia. 2016;107:501–508. DOI: 10.5935/abc.20160190
- Hobbs FR, Taylor CJ, Jan Geersing G, Rutten FH, Brouwer JR, European Primary Care Cardiovascular Society Swg. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care. European Journal of Preventive Cardiology. 2016;23:460–473. DOI: 10.1177/2047487315571890
- Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, et al. Screening for atrial fibrillation: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Europace. 2017;19:1589–1623. DOI: 10.1093/europace/eux177
- Joung B, Lee JM, Lee KH, Kim TH, Choi EK, Lim WH, et al. 2018 Korean guideline of atrial fibrillation management. Korean Circulation Journal. 2018;48:1033–1080. DOI: 10.4070/kcj.2018.0339
- Freedman B, Hindricks G, Banerjee A, Baranchuk A, Ching CK, Du X, et al. World Heart Federation Roadmap on Atrial Fibrillation – A 2020 update. Global Heart. 2021;16:
41 . DOI: 10.5334/gh.1023 - Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC, et al. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. Canadian Journal of Cardiology. 2020;36:1847–1948. DOI: 10.1016/j.cjca.2020.09.001
- Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for atrial fibrillation: US preventive services task force recommendation statement. JAMA. 2022;327:360–367. DOI: 10.1001/jama.2021.23732
- Ma C, Wu S, Liu S, Han Y. Chinese guidelines for the diagnosis and management of atrial fibrillation. Pacing and Clinical Electrophysiology. 2024;47:714–770. DOI: 10.1111/pace.14920
- Aotearoa New Zealand. Guidelines for the Prevention, Diagnosis, and Management of Acute Rheumatic Fever and Rheumatic Heart Disease, 2024 Updated.
https://www.tewhatuora.govt.nz/assets/Publications/Rheumatic-fever/Aotearoa-New-Zealand-Guidelines-for-the-Prevention-Diagnosis-and-Management-of-Acute-Rheumatic-Fever-and-Rheumatic-Heart-Disease.pdf ; 2024. - Ministry of Health and Medical Services Fiji. Fiji guidelines for the diagnosis, management and prevention of acute rheumatic fever and rheumatic heart disease. Ministry of Health and Medical Services.
https://www.health.gov.fj/wp-content/uploads/2019/08/Fiji-Guidelines-for-Acute-Rheumatic-Fever-and-Rheumatic-Heart-Disease-Diagnosis-Management-and-Prevention.pdf ; 2017. - Ministry of Health Kenya. Kenya national guidelines for cardiovascular diseases management 2018. Public Policy Repository. Ministry of Health.
https://repository.kippra.or.ke/handle/123456789/1791 ; 2018. - Ali Sulafa KM, Karrar ZA, Elkurdufani N, Ibrahim N. Sudan’s rheumatic fever and rheumatic heart disease guidelines: A simplified approach in an endemic country. Frontiers of Cardiovascular Medicine. 2024;11:
1403131 . DOI: 10.3389/fcvm.2024.1403131 - Menzies School of Health Research (ARF/RHD writing group). Australian guideline for the prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (Edition 3.3).
https://rhdaustralia.org.au/wp-content/uploads/2025/08/Australian-ARF-RHD-Guideline-2025_August.pdf . - Government of Western Cape. Primary prevention and prophylaxis of rheumatic fever and rheumatic heart disease for health professionals at primary level.
https://d7.westerncape.gov.za/sites/www.westerncape.gov.za/files/documents/2003/rheuma.pdf ; 2003. - Government of India. Handbook on prevention and control of rheumatic fever & heart disease.
https://www.mohfw.gov.in/sites/default/files/Handbook%20on%20Prevention%20and%20Control%20of%20Rheumatic%20Fever%20%26%20Heart%20Diesease%20%282015%29_0.pdf . - World Health Assembly. Rheumatic fever and rheumatic heart disease: Report by the Director-General. Geneva: World Health Organization; 2018.
- Western Australia Country Health Service and Kimberley Aboriginal Medical Services Council. Rheumatic Heart Disease – Kimberley Chronic Disease Guideline.
https://www.health.wa.gov.au/~/media/Files/Corporate/general%20documents/Medical%20notifications/PDF/rheumatic-heart-disease-kimberley-chronic-disease-guideline.pdf . - Communicable Diseases Network Australia. Acute rheumatic fever & rheumatic heart disease.
https://www.health.nsw.gov.au/Infectious/controlguideline/Documents/arf-rhd-song.pdf . - Kumar RK, Antunes MJ, Beaton A, Mirabel M, Nkomo VT, Okello E, et al. Contemporary diagnosis and management of rheumatic heart disease: Implications for closing the gap: A scientific statement from the American Heart Association. Circulation. 2020;142:e337–e357. DOI: 10.1161/CIR.0000000000000921
- Izumi C, Eishi K, Ashihara K, Arita T, Otsuji Y, Kunihara T, et al. JCS/JSCS/JATS/JSVS 2020 Guidelines on the management of valvular heart disease. Circulation Journal. 2020;84:2037–2119. DOI: 10.1253/circj.CJ-20-0135
- Jaimes-Reyes MA, Urina-Jassir M, Urina-Triana M, Urina-Triana M. Current situation of acute rheumatic fever and rheumatic heart disease in Latin America and the Caribbean: A systematic review. Global Heart. 2022;17:
65 . DOI: 10.5334/gh.1152. - Shawar YR, Shiffman J. Generating global priority for addressing rheumatic heart disease: A qualitative policy analysis. Journal of the American Heart Association. 2020;9:
e014800 . DOI: 10.1161/JAHA.119.014800 - Belay W, Aliyu MH. Rheumatic heart disease is missing from the global health agenda. Annals of Global Health. 2021;87:
110 . DOI: 10.5334/aogh.3426 - Negi PC, Sondhi S, Rana V, Rathoure S, Kumar R, Kolte N, et al. Prevalence, risk determinants and consequences of atrial fibrillation in rheumatic heart disease: 6 years hospital based-Himachal Pradesh- Rheumatic Fever/Rheumatic Heart Disease (HP-RF/RHD) Registry. Indian Heart Journal. 2018;70 Suppl 3:S68–S73. DOI: 10.1016/j.ihj.2018.05.013
- Diker E, Aydogdu S, Ozdemir M, Kural T, Polat K, Cehreli S, et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. American Journal of Cardiology. 1996;77:96–98. DOI: 10.1016/s0002-9149(97)89145-x
- Acar J, Michel PL, Cormier B, Vahanian A, Iung B. Features of patients with severe mitral stenosis with respect to atrial rhythm. Atrial fibrillation in predominant and tight mitral stenosis. Acta Cardiologica. 1992;47:115–124.
- Gupta A, Bhatia R, Sharma G, Prasad K, Singh MB, Vibha D. Predictors of ischemic stroke in rheumatic heart disease. Journal of Stroke and Cerebrovascular Diseases. 2015;24:2810–2815. DOI: 10.1016/j.jstrokecerebrovasdis.2015.08.014
- Wolf PA. Awareness of the role of atrial fibrillation as a cause of ischemic stroke. Stroke. 2014;45:e19–e21. DOI: 10.1161/STROKEAHA.113.003282
- Lip GY, Boos CJ. Antithrombotic treatment in atrial fibrillation. Heart. 2006;92:155–161. DOI: 10.1136/hrt.2005.066944
- Emmerich J, Le Heuzey J-Y, Bath PMW, Connolly SJ. Indication for antithrombotic therapy for atrial fibrillation: Reconciling the guidelines with clinical practice. European Heart Journal Supplements. 2005;7:C28–C33. DOI: 10.1093/eurheartj/sui017
- Tang H, Zhang K, Chen J, Zhang X, Yu X, Ren J, et al. Global burden of rheumatic vs non-rheumatic valvular heart disease, 1990–2021: A systematic analysis of the global burden of disease study. Clinical Rheumatology. 2025;44:4807–4817. DOI: 10.1007/s10067-025-07739-8
- Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ. 2018;190:E422–E429. DOI: 10.1503/cmaj.171154
- Essien UR, Kornej J, Johnson AE, Schulson LB, Benjamin EJ, Magnani JW. Social determinants of atrial fibrillation. Nature Reviews Cardiology. 2021;18:763–773. DOI: 10.1038/s41569-021-00561-0
- Wald NJ. The definition of screening. Journal of Medical Screening. 2001;8:
1 . DOI: 10.1136/jms.8.1.1 - Wong KC, Nguyen TN, Chow CK. Global implementation and evaluation of atrial fibrillation screening in the past two decades – A narrative review. NPJ Cardiovascular Health. 2024;1:
17 . DOI: 10.1038/s44325-024-00014-w - Theunissen L, Abdalrahim R, Dekker LRC, Thijssen EJM, de Jong S, Polak PE, et al. Regional implementation of atrial fibrillation screening: benefits and pitfalls. European Heart Journal – Digital Health. 2022;3:570–577. DOI: 10.1093/ehjdh/ztac055
- Santos IS, Goulart AC, Olmos RD, Thomas GN, Lip GYH, Lotufo PA, et al. Atrial fibrillation in low- and middle-income countries: a narrative review. European Heart Journal Supplements. 2020;22:O61–O77. DOI: 10.1093/eurheartj/suaa181
- Machado AM, Leite F, Pereira MG. Integrated care in atrial fibrillation: A multidisciplinary approach to improve clinical outcomes and quality of life. Healthcare (Basel). 2025;13. DOI: 10.3390/healthcare13030325
DOI: https://doi.org/10.5334/gh.1552 | Journal eISSN: 2211-8179
Language: English
Page range: 37 - 37
Submitted on: Jan 2, 2026
Accepted on: Apr 15, 2026
Published on: Apr 28, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2026 Elizabeth Paratz, Xinying Zhou, Caio A. M. Tavares, Priyansh Shah, Julian Hoevelmann, Menglu Ouyang, Diana H. P. Foo, Amitava Banerjee, Ben Freedman, James Marangou, Jessica J. Orchard, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.